{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:59:27Z","timestamp":1790895567867,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":232,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"FWO-Vlaanderen","award":["G081121N"],"award-info":[{"award-number":["G081121N"]}]},{"name":"FWO-Vlaanderen","award":["postdoctoral fellowship"],"award-info":[{"award-number":["postdoctoral fellowship"]}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"crossref","award":["C14\/18\/102"],"award-info":[{"award-number":["C14\/18\/102"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13311-023-01365-5","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T09:02:56Z","timestamp":1681376576000},"page":"67-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u237a-Synuclein Structural Diversity and the Cellular Environment in \u237a-Synuclein Transmission Models and Humans"],"prefix":"10.1016","volume":"20","author":[{"given":"Wouter","family":"Peelaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8966-2921","authenticated-orcid":false,"given":"Veerle","family":"Baekelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01365-5_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1007\/s13311-023-01365-5_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"377","author":"Nalls","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1007\/s13311-023-01365-5_bib3","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.1007\/s13311-023-01365-5_bib4","author":"Grazia Spillantini","year":"1998","journal-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett"},{"key":"10.1007\/s13311-023-01365-5_bib5","first-page":"1","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib6","unstructured":"L\u00f6vestam S, Schweighauser M, Matsubara T, et al. Seeded assembly in vitro does not replicate the structures of a-synuclein filaments from multiple system atrophy."},{"key":"10.1007\/s13311-023-01365-5_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib8","first-page":"1","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0000000000200878","article-title":"\u03b1-Synuclein seed amplification assays for diagnosing synucleinopathies","volume":"99","author":"Bellomo","year":"2022","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01365-5_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fnagi.2022.872629","article-title":"The future of seed amplification assays and clinical trials","volume":"14","author":"Coysh","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib11","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00702-021-02419-8","article-title":"A historical review of multiple system atrophy with a critical appraisal of cellular and animal models","volume":"128","author":"Marmion","year":"2021","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-023-01365-5_bib12","doi-asserted-by":"crossref","first-page":"134316","DOI":"10.1016\/j.neulet.2019.134316","article-title":"\u03b1-Synuclein pathology in Parkinson's disease and related \u03b1-synucleinopathies","volume":"709","author":"Henderson","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-023-01365-5_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of \u03b1-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01365-5_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","article-title":"\u0251-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences","volume":"373","author":"Peelaerts","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1007\/s13311-023-01365-5_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib17","article-title":"Host oligodendrogliopathy and \u0251-synuclein strains dictate disease severity in multiple system atrophy","author":"Torre-Muruzabal","year":"2022","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01365-5_bib18","first-page":"1","article-title":"Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris","author":"Schaum","year":"2018","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib19","unstructured":"Pande R, Huang Y, Teeple E, et al. Single cell atlas of human putamen reveals disease specific changes in synucleinopathies: Parkinson's disease and multiple system atrophy."},{"key":"10.1007\/s13311-023-01365-5_bib20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.1252884","article-title":"Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins","volume":"344","author":"Wilhelm","year":"2014","journal-title":"Science"},{"key":"10.1007\/s13311-023-01365-5_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fcell.2020.573696","article-title":"Alpha synuclein connects the gut-brain axis in Parkinson's disease patients \u2013 a view on clinical aspects, cellular pathology and analytical methodology","volume":"8","author":"Schaeffer","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1007\/s13311-023-01365-5_bib22","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"10.1007\/s13311-023-01365-5_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1007\/s13311-023-01365-5_bib24","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophys J"},{"key":"10.1007\/s13311-023-01365-5_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21027-4","article-title":"The docking of synaptic vesicles on the presynaptic membrane induced by \u03b1-synuclein is modulated by lipid composition","volume":"12","author":"Man","year":"2021","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01365-5_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tcb.2017.02.002","article-title":"\u03b1-Synuclein, regulator of exocytosis, endocytosis, or both?","volume":"27","author":"Lautenschl\u00e4ger","year":"2017","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1007\/s13311-023-01365-5_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction","volume":"9","author":"Lautenschl\u00e4ger","year":"2018","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01365-5_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01365-5_bib29","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01365-5_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbamem.2011.07.032","article-title":"Biophysics of \u03b1-synuclein membrane interactions","volume":"1818","author":"Pfefferkorn","year":"2012","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10.1007\/s13311-023-01365-5_bib31","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","article-title":"The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability","volume":"185","author":"Hallacli","year":"2022","journal-title":"Cell"},{"key":"10.1007\/s13311-023-01365-5_bib32","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cell biology and pathophysiology of \u03b1-synuclein. Cold Spring Harb Perspect Med"},{"key":"10.1007\/s13311-023-01365-5_bib33","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fncel.2021.633727","article-title":"The membrane interaction of alpha-synuclein","volume":"15","author":"Liu","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib35","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbamem.2011.09.008","article-title":"Folding and misfolding of alpha-synuclein on membranes","volume":"1818","author":"Dikiy","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-023-01365-5_bib36","doi-asserted-by":"crossref","first-page":"21416","DOI":"10.1074\/jbc.M110.103499","article-title":"Regulation of Weibel-Palade body exocytosis by \u03b1-synuclein in endothelial cells","volume":"285","author":"Kim","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01365-5_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)00297-5","article-title":"Expression of \u03b1-synuclein, the precursor of non-amyloid \u03b2 component of Alzheimer's disease amyloid, in human cerebral blood vessels","volume":"326","author":"Tamo","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-023-01365-5_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.562692","article-title":"Intracellular alpha-synuclein and immune cell function","author":"Grozdanov","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1007\/s13311-023-01365-5_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105654","article-title":"Upregulation of \u03b1-synuclein following immune activation: possible trigger of Parkinson's disease","volume":"166","author":"Kasen","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01365-5_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1007\/s13311-023-01365-5_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02590","article-title":"Alpha synuclein in hematopoiesis and immunity","volume":"5","author":"Pei","year":"2019","journal-title":"Heliyon"},{"key":"10.1007\/s13311-023-01365-5_bib42","first-page":"299","article-title":"Can infections trigger alpha-synucleinopathies? Mol Biol Neurodegener Dis Visions Futur Part A","author":"Tulisiak","year":"2019","journal-title":"Elsevier"},{"key":"10.1007\/s13311-023-01365-5_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110090","article-title":"Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function","volume":"38","author":"Alam","year":"2022","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01365-5_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac192","article-title":"Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue","author":"Monogue","year":"2022","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01365-5_bib45","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/JVI.02949-15","article-title":"Alpha-synuclein expression restricts RNA viral infections in the brain","volume":"90","author":"Beatman","year":"2015","journal-title":"J Virol"},{"key":"10.1007\/s13311-023-01365-5_bib46","doi-asserted-by":"crossref","DOI":"10.1089\/dna.2016.3488","article-title":"Alpha-synuclein, a novel viral restriction factor hiding in plain sight","author":"Massey","year":"2016","journal-title":"DNA Cell Biol"},{"key":"10.1007\/s13311-023-01365-5_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158376","article-title":"Norovirus intestinal infection and Lewy body disease in an older patient with acute cognitive impairment","volume":"23","author":"Moreno-Valladares","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-023-01365-5_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138920309789351921","article-title":"Biophysics of Parkinson's disease: structure and aggregation of \u03b1-synuclein","volume":"10","author":"Uversky","year":"2009","journal-title":"Curr Protein Pept Sci"},{"key":"10.1007\/s13311-023-01365-5_bib49","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of \u03b1-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc Chem Res"},{"key":"10.1007\/s13311-023-01365-5_bib50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-023-01365-5_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.10.021","article-title":"\u03b1-Synuclein aggregation and its modulation","volume":"100","author":"Ghosh","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1007\/s13311-023-01365-5_bib52","doi-asserted-by":"crossref","first-page":"7854","DOI":"10.1039\/C8CC03002B","article-title":"Kinetic barriers to \u03b1-synuclein protofilament formation and conversion into mature fibrils","volume":"54","author":"Brown","year":"2018","journal-title":"Chem Commun"},{"key":"10.1007\/s13311-023-01365-5_bib53","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1007\/s13311-023-01365-5_bib54","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/S0033583516000172","article-title":"Secondary nucleation of monomers on fibril surface dominates \u03b1-synuclein aggregation and provides autocatalytic amyloid amplification","volume":"50","author":"Gaspar","year":"2017","journal-title":"Q Rev Biophys"},{"key":"10.1007\/s13311-023-01365-5_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","article-title":"Structural characteristics of \u03b1-synuclein oligomers","volume":"329","author":"Cremades","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1007\/s13311-023-01365-5_bib56","first-page":"E1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01365-5_bib58","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"10.1007\/s13311-023-01365-5_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"\u03b1-Synuclein misfolding and Parkinson's disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"10.1007\/s13311-023-01365-5_bib60","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01365-5_bib61","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib62","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-023-01365-5_bib63","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1007\/s13311-023-01365-5_bib64","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01365-5_bib65","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1084\/jem.20160368","article-title":"Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease","volume":"213","author":"Rey","year":"2016","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-023-01365-5_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0142-z","article-title":"Inflammatory pre-conditioning restricts the seeded induction of \u03b1-synuclein pathology in wild type mice","volume":"12","author":"Koller","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01365-5_bib67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01365-5_bib68","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","article-title":"Progressive aggregation of alpha-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism","volume":"10","author":"Osterberg","year":"2015","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01365-5_bib69","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","article-title":"Defining \u03b1-synuclein species responsible for Parkinson's disease phenotypes in mice","volume":"294","author":"Froula","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01365-5_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nbd.2017.05.014","article-title":"\u237a-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic neurodegeneration","volume":"105","author":"Abdelmotilib","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01365-5_bib72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","article-title":"Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term","volume":"135","author":"Rey","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib73","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","article-title":"Differential \u03b1-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity","volume":"135","author":"Luna","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1007\/s13311-023-01365-5_bib75","article-title":"Exposure to bacterial endotoxin generates a distinct strain of \u03b1-synuclein fibril","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01365-5_bib76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-021-02316-0","article-title":"Multiple system atrophy-associated oligodendroglial protein p25\u03b1 stimulates formation of novel \u03b1-synuclein strain with enhanced neurodegenerative potential","volume":"142","author":"Ferreira","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"\u03b1-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-021-00242-5","article-title":"Differential seeding and propagating efficiency of \u03b1-synuclein strains generated in different conditions","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1007\/s13311-023-01365-5_bib79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-019-01959-4","article-title":"Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines","volume":"137","author":"Woerman","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib80","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib81","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van Der Perren","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib82","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib83","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01365-5_bib84","first-page":"1","article-title":"Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein","author":"Bernis","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01365-5_bib85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-019-0733-3","article-title":"Comparative analyses of the in vivo induction and transmission of \u03b1-synuclein pathology in transgenic mice by MSA brain lysate and recombinant \u03b1-synuclein fibrils","volume":"7","author":"Dhillon","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01365-5_bib86","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","article-title":"Prion-like acceleration of a synucleinopathy in a transgenic mouse model","volume":"33","author":"Mougenot","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01365-5_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03948-y","article-title":"Quaternary structure of patient-homogenate amplified \u03b1-synuclein fibrils modulates seeding of endogenous \u03b1-synuclein","volume":"5","author":"Frieg","year":"2022","journal-title":"Commun Biol"},{"key":"10.1007\/s13311-023-01365-5_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13564-w","article-title":"Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts","volume":"10","author":"Stroh\u00e4ker","year":"2019","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01365-5_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23682-z","article-title":"Phenotypic manifestation of \u03b1-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons","volume":"12","author":"Tanudjojo","year":"2021","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01365-5_bib90","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114405119","article-title":"In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain","volume":"119","author":"Killinger","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib91","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib92","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-021-02329-9","article-title":"The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy","volume":"142","author":"Moors","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib93","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein","volume":"26","author":"Zhang","year":"2023","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib94","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109617119","article-title":"\u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","volume":"119","author":"Ghanem","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib95","first-page":"1","article-title":"Phosphorylation induces distinct alpha-synuclein strain formation","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01365-5_bib96","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","article-title":"Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis","volume":"22","author":"Henderson","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc2487","article-title":"Determinants of seeding and spreading of \u03b1-synuclein pathology in the brain","volume":"6","author":"Henrich","year":"2020","journal-title":"Sci Adv"},{"key":"10.1007\/s13311-023-01365-5_bib98","doi-asserted-by":"crossref","first-page":"104623","DOI":"10.1016\/j.nbd.2019.104623","article-title":"Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: involvement of retrograde and anterograde axonal propagation","volume":"134","author":"Mezias","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01365-5_bib99","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","article-title":"G2019S-LRRK2 expression augments \u03b1-synuclein sequestration into inclusions in neurons","volume":"36","author":"Volpicelli-Daley","year":"2016","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00401-019-01995-0","article-title":"LRRK2 modifies \u03b1-syn pathology and spread in mouse models and human neurons","volume":"137","author":"Bieri","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib101","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","article-title":"Glucocerebrosidase activity modulates neuronal susceptibility to pathological \u03b1-synuclein insult","volume":"105","author":"Henderson","year":"2020","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01365-5_bib102","doi-asserted-by":"crossref","first-page":"e0238075","DOI":"10.1371\/journal.pone.0238075","article-title":"L444P Gba1 mutation increases formation and spread of \u03b1-synuclein deposits in mice injected with mouse \u03b1-synuclein pre-formed fibrils","volume":"15","author":"Migdalska-Richards","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01365-5_bib103","doi-asserted-by":"crossref","first-page":"105513","DOI":"10.1016\/j.nbd.2021.105513","article-title":"Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological \u03b1-synuclein spread in the prodromal preformed fibrils model in young mice","volume":"159","author":"Johnson","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01365-5_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0840-1","article-title":"Luminescent conjugated oligothiophenes distinguish between \u03b1-synuclein assemblies of Parkinson's disease and multiple system atrophy","volume":"7","author":"Klingstedt","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01365-5_bib105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib106","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-023-01365-5_bib107","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-021-02266-7","article-title":"Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders","volume":"141","author":"Erskine","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib108","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1039\/c1ob05637a","article-title":"Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates","volume":"9","author":"Klingstedt","year":"2011","journal-title":"Org Biomol Chem"},{"key":"10.1007\/s13311-023-01365-5_bib109","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01365-5_bib110","first-page":"1","article-title":"A novel grading scale for striatonigral degeneration (multiple system atrophy)","author":"Wenning","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-023-01365-5_bib111","first-page":"1","article-title":"Similar neuronal imprint and no cross-seeded fibrils in \u03b1-synuclein aggregates from MSA and Parkinson's disease","volume":"8","author":"Laferri\u00e8re","year":"2022","journal-title":"NPJ Park Dis"},{"key":"10.1007\/s13311-023-01365-5_bib112","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.1073\/pnas.0905936106","article-title":"Human myelin proteome and comparative analysis with mouse myelin","volume":"106","author":"Ishii","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01365-5_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108132","article-title":"Cell-type- and brain-region-resolved mouse brain lipidome","volume":"32","author":"Fitzner","year":"2020","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01365-5_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/glia.22653","article-title":"Alpha-synuclein mRNA expression in oligodendrocytes in MSA","author":"Asi","year":"2014","journal-title":"Glia"},{"key":"10.1007\/s13311-023-01365-5_bib115","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","article-title":"Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia","volume":"112","author":"Miller","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-023-01365-5_bib116","unstructured":"Dulken BW, Buckley MT, Negredo PN, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches."},{"key":"10.1007\/s13311-023-01365-5_bib117","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","article-title":"A shared disease-associated oligodendrocyte signature among multiple CNS pathologies","volume":"25","author":"Kenigsbuch","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib118","author":"J\u00e4kel","year":"2019","journal-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature"},{"key":"10.1007\/s13311-023-01365-5_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01365-5_bib120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000479653","article-title":"Alpha-synuclein to the rescue: immune cell recruitment by alpha-synuclein during gastrointestinal infection","volume":"9","author":"Labrie","year":"2017","journal-title":"J Innate Immun"},{"key":"10.1007\/s13311-023-01365-5_bib121","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4103\/1673-5374.235013","article-title":"Subcellular localization of alpha-synuclein aggregates and their interaction with membranes","volume":"13","author":"Miraglia","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1007\/s13311-023-01365-5_bib122","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.28925","article-title":"Infectious agents as potential drivers of \u03b1-synucleinopathies","volume":"37","author":"Linard","year":"2022","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01365-5_bib123","first-page":"1","article-title":"Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice","volume":"2","author":"Pan-Montojo","year":"2012","journal-title":"Sci Reports"},{"key":"10.1007\/s13311-023-01365-5_bib124","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7554\/eLife.53111","article-title":"A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice","volume":"9","author":"Sampson","year":"2020","journal-title":"Elife"},{"key":"10.1007\/s13311-023-01365-5_bib125","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1021\/acschemneuro.0c00671","article-title":"Viral infection-induced gut dysbiosis, neuroinflammation, and \u03b1-synuclein aggregation: updates and perspectives on COVID-19 and neurodegenerative disorders","volume":"11","author":"Follmer","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28185","article-title":"The possible protective role of \u03b1-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease","author":"Ait Wahmane","year":"2020","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01365-5_bib127","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1042\/NS20170166","article-title":"A role for viral infections in Parkinson's etiology?","volume":"2","author":"Olsen","year":"2018","journal-title":"Neuronal Signal"},{"key":"10.1007\/s13311-023-01365-5_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5280","article-title":"The vermiform appendix impacts the risk of developing Parkinson's disease","volume":"10","author":"Killinger","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-023-01365-5_bib129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01365-5_bib131","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","article-title":"Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats","volume":"138","author":"Van Den Berge","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01365-5_bib132","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/brain\/awab061","article-title":"Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats","volume":"144","author":"Van Den Berge","year":"2021","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01365-5_bib133","first-page":"1","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","author":"Challis","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01365-5_bib134","doi-asserted-by":"crossref","first-page":"101166","DOI":"10.1016\/j.isci.2020.101166","article-title":"Propagation of pathological \u03b1-synuclein from the urogenital tract to the brain initiates MSA-like syndrome","volume":"23","author":"Ding","year":"2020","journal-title":"iScience"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01365-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01365-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01365-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:33:47Z","timestamp":1761806027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792300106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S187874792300106X"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01365-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u237a-Synuclein Structural Diversity and the Cellular Environment in \u237a-Synuclein Transmission Models and Humans","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01365-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}